On Holding Executives and Founder Increase Stake in Company ASML Holding NV ASML Gains Attention as Oversold Growth Stock Amid Semiconductor Market Shifts USIran Tensions and Tech Highlights Morning Market Overview Signos Secures 20M Funding Expands Dexcom Partnership in GLP1 Weight Loss Wave AI in Filmmaking Cannes Summit Highlights Industry Divisions Over Generative Technology Fairholme Trims Stake in St Joe Company but the Investment Thesis Remains Intact ING Q1 2026 Earnings EPS Beats Estimates by 66 as Provisions Remain Contained Hallador Energy Q1 2026 Earnings EPS Misses Estimates Stock Rises on Operational Developments SPOT Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Sentiment Moving iMage Technologies Inc MITQ Q1 2026 Earnings Net Loss Reported as Stock Edges Higher American Vanguard Corporation AVD Q3 2025 Earnings Deep EPS Miss and Steep Stock Decline Highlight Operational Headwinds MYPS Q1 2026 Earnings EPS Misses Estimates but Stock Rises Over 6 Waste Management WM Slips 11 as Defensive Sector Faces Headwinds Holds Above Key Support Power Solutions International PSIX Edges Higher as Stock Tests Resistance Levels Hawaiian Electric HE Gains Modestly as Support Holds Above 13 Axogen Inc AXGN Edges Lower Amid Sector Rotation Key Support Levels in Focus Artiva Biotherapeutics Holds Steady with Slight Gain Support at 75 in Focus ARTV Meta Settles Landmark Social Media Addiction Lawsuit with US School District Sets Precedent for Hundreds of Similar Cases AnalystFavored Stocks Show Strong Earnings Growth Potential Five Below Fabrinet Alamos Gold Among Seven Picks Kevin Warsh to Be Sworn In as Federal Reserve Chair on Friday Coal India Plans Syngas Projects to Offset Tightening Gas Supply for Power and Fertilizer Sectors Ella Langley Achieves Historic Billboard Hot 100 Milestone for Country Music SP 500 and Nasdaq Hold Steady as Investors Watch for Middle East Peace Developments Walmart Inc Analyst Report Highlights Key Opportunities in Retail Sector SGRP Q4 2024 Earnings EPS Misses Estimates Amidst Undisclosed Revenue Nektar Therapeutics NKTR Fades 287 as Biotech Stock Tests Key Support Levels